Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
CNS & Neurological Disorders Drug Targets|April 19, 2023
Role of Lipocalin-2 in N1/N2 Neutrophil Polarization After StrokeZhiliang Guo, Guoli Xu, Jiaping Xu, et al.
BMC Neuroscience|June 3, 2025
Eosinophils differentially affect early and delayed neurological deterioration after mechanical thrombectomy in strokeShuhong Yu, Jinping Yang, Xiaoting Han, et al.
Molecular Medicine Reports|August 12, 2024
Chitinase‑3 like‑protein‑1: A potential predictor of cardiovascular disease (Review)Zhuojian Qu, Yirui Lu, Yutong Ran, et al.
Brain Research Bulletin|May 1, 2021
Ferroptosis and traumatic brain injuryZhiwen Geng, Zhiliang Guo, Ruibing Guo, et al.
CNS & Neurological Disorders Drug Targets|March 22, 2016
NLRP3 Is Involved in Ischemia/Reperfusion InjuryZhiliang Guo, Shuhong Yu, Xin Chen, et al.
Frontiers in Immunology|May 3, 2021
Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific AntibodiesLan Zhu, Zhiliang Guo, Rula Sa, et al.
The American Journal of Case Reports|November 5, 2025
Pregnancy and Lactation-Associated Osteoporotic Spinal Fractures: A Case ReportWenhua Lan, Zhiliang Guo, Yongtian Jiang, et al.
Journal of Physiology and Biochemistry|October 21, 2025
Effects and mechanisms of MSCs and MSC-derived exosomes in regulating ferroptosisZhiliang Guo, Zhuojian Qu, Yubing Zhang, et al.
Oncology Letters|February 7, 2022
Neoantigens and their potential applications in tumor immunotherapyXianzhu Fang, Zhiliang Guo, Jinqing Liang, et al.
BMC Nephrology|January 11, 2025
Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot studyZhiliang Guo, Rula Sa, Daqiang Zhao, et al.
Pageof 8